Genetic inhibition of Ral GTPase activity consistently prevented hyperproliferation in these models, suggesting that targeting RAL function could be a potentially effective therapeutic approach in the treatment of multiple highly aggressive cancer types. The gene discussed is RALA; the disease is cancer.